Coyne Terrance P.

CIK 00018148761 companyNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001814876

Recent Transactions

50 trades

Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2026-01-20$39.35/sh−3,750→ 36,010 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2026-01-20$39.35/sh−65,832→ 394,996 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2026-01-02$38.42/sh−65,832→ 460,828 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2026-01-02$38.42/sh−3,750→ 39,760 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-12-15$38.36/sh−65,832→ 526,660 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-12-15$38.36/sh−3,750→ 43,510 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-12-01$39.87/sh−65,832→ 592,492 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-12-01$39.87/sh−3,750→ 47,260 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-11-24$38.67/sh−55,146→ 669,010 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-11-24$37.96/sh−10,686→ 658,324 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-11-24$37.96/sh−624→ 51,010 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-11-24$38.67/sh−3,126→ 51,634 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-11-17$39.30/sh−3,750→ 54,760 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-11-17$39.30/sh−65,844→ 724,156 total
Award
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-11-05+6,168→ 58,510 total
Gift
Royalty Pharma plc$RPRX
LP interests in RPI US Partners 2019, LP
2025-08-08−1,000→ 43,350 total
Award
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-08-06+3,696→ 52,342 total
Award
Royalty Pharma plc$RPRX
Class E Ordinary Shares
2025-05-16+1,807,277→ 1,807,277 total
Award
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-05-08+48,646→ 48,646 total
Gift
Royalty Pharma plc$RPRX
ICAI Interests
2024-08-12−2,000→ 44,350 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2023-08-10$30.75/sh−37,500→ 790,000 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2023-08-09$30.72/sh−37,500→ 827,500 total
Gift
Royalty Pharma plc$RPRX
ICAI Interests
2023-08-08−1,650→ 46,350 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2023-07-13$30.93/sh−37,500→ 865,000 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2023-07-12$31.07/sh−37,500→ 902,500 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2022-11-08$43.47/sh−24,500→ 940,000 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2022-11-02$43.06/sh−5,500→ 964,500 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2022-08-01$43.19/sh−30,000→ 970,000 total
Conversion
Royalty Pharma plc$RPRX
LP interests in RPI US Partners 2019, LP
2021-05-07−100,000→ 22,945 total
Conversion
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2021-05-07+1,000,000→ 1,000,000 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2021-03-03$46.83/sh−1,456→ 200,000 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2021-03-03$45.86/sh−11,001→ 201,456 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2021-03-03$43.71/sh−29,820→ 270,180 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2021-03-03$45.09/sh−57,723→ 212,457 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2021-03-02$47.88/sh−5,022→ 300,000 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2021-03-02$46.89/sh−94,978→ 305,022 total
Conversion
Royalty Pharma plc$RPRX
LP interests in RPI US Partners 2019, LP
2020-12-31−9,977→ 778 total
Conversion
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2020-12-31+300,230→ 400,000 total
Conversion
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2020-12-31+99,770→ 99,770 total
Conversion
Royalty Pharma plc$RPRX
LP interests in RPI US Partners 2019, LP
2020-12-31−30,023→ 376,468 total
Conversion
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2020-06-18+23,270→ 23,270 total
Purchase
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2020-06-18$28.00/sh+1,500→ 1,500 total
Conversion
Royalty Pharma plc$RPRX
LP interests in RPI International Holdings 2019, LP
2020-06-18−2,327→ 181 total
Purchase
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2020-06-18$28.00/sh+1,450→ 1,450 total
Conversion
Royalty Pharma plc$RPRX
LP interests in RPI International Holdings 2019, LP
2020-06-18−2,417→ 188 total
Conversion
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2020-06-18+24,170→ 24,170 total
Award
Royalty Pharma plc$RPRX
LP interests in RPI US Partners 2019, LP
2020-06-15+406,491→ 406,491 total
Award
Royalty Pharma plc$RPRX
LP interests in RPI International Holdings 2019, LP
2020-06-15+2,605→ 2,605 total
Award
Royalty Pharma plc$RPRX
LP interests in RPI US Partners 2019, LP
2020-06-15+10,755→ 10,755 total
Award
Royalty Pharma plc$RPRX
ICAI Interests
2020-06-15+305,000→ 305,000 total

Companies

Royalty Pharma plc
EVP & CFO
$RPRX

Recent Filings

Address

C/O ROYALTY PHARMA PLC 110 EAST 59TH STREET

NEW YORK, NY, 10022

View on SEC.gov